loadpatents
Patent applications and USPTO patent grants for Guarracino; Danielle.The latest application filed is for "oxopiperazine helix mimetics as inhibitors of the p53-mdm2 interaction".
Patent | Date |
---|---|
Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction Grant 11,180,481 - Arora , et al. November 23, 2 | 2021-11-23 |
Oligooxopiperazines and methods of making and using them Grant 9,624,203 - Arora , et al. April 18, 2 | 2017-04-18 |
OXOPIPERAZINE HELIX MIMETICS AS INHIBITORS OF THE p53-MDM2 INTERACTION App 20170037033 - ARORA; Paramjit S. ;   et al. | 2017-02-09 |
Oligooxopiperazines And Methods Of Making And Using Them App 20160214965 - ARORA; Paramjit S. ;   et al. | 2016-07-28 |
Oligooxopiperazines and methods of making and using them Grant 9,309,230 - Arora , et al. April 12, 2 | 2016-04-12 |
Oligooxopiperazines And Methods Of Making And Using Them App 20150072991 - ARORA; Paramjit S. ;   et al. | 2015-03-12 |
Oligooxopiperazines and methods of making and using them Grant 8,791,121 - Arora , et al. July 29, 2 | 2014-07-29 |
Oligooxopiperazines And Methods Of Making And Using Them App 20120040992 - Arora; Paramjit S. ;   et al. | 2012-02-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.